Interv Akut Kardiol. 2021;20(2):93-97 | DOI: 10.36290/kar.2021.027

Problems of care for STEMI patients in coronavirus pandemic

Stanislav Šimek
Fyziologický ústav a II. interní klinika kardiologie a angiologie, 1. lékařská fakulta Univerzity Karlovy, Praha

The covid-19 pandemic negatively affects time-dependent care and the course of STEMI in several aspects: Conclusion: It is apparent that STEMI in covid-19 infected patients is not the same disease process as STEMI that without covid-19 infection. Patients with STEMI and covid-19 have a higher risk of heart failure, cardiac arrest, cardiogenic shock, greater intracoronary thrombosis and stent thrombosis, resulting in higher cardiac and non-cardiac mortality. Aggressive antithrombotic treatment is recommended. Even in the covid era it is essential to insist on timely treatment of STEMI. Training of cardiac catheterization personnel on how to use personal protective equipment as well as vaccination are crucial to limit the risk of acquiring infection.

Keywords: STEMI, covid, treatment, prognosis.

Published: July 9, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Šimek S. Problems of care for STEMI patients in coronavirus pandemic. Interv Akut Kardiol. 2021;20(2):93-97. doi: 10.36290/kar.2021.027.
Zobrazit celý článek

Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Choudry FA, Hamshere SM, Rathod KS, et al. High Thrombus Burden in Patients With covid-19 Presenting With ST-Segment Elevation Myocardial Infarction. J Am Coll Cardiol. 2020; 76(10): 1168-1176. doi: 10.1016/j.jacc.2020.07.022. Epub 2020 Jul 14. PMID: 32679155; PMCID: PMC7833185. Go to original source... Go to PubMed...
    2. Bangalore S, Sharma A, Slotwiner A, et al. ST-Segment Elevation In Patients With covid-19 - A Case Series. N Engl J Med. 2020; 382: 2478-2480. Go to original source... Go to PubMed...
    3. Stefanini GG, Montorfano M, Trabattoni D, et al. ST-Elevation Myocardial Infarction in Patients With covid-19: Clinical and Angiographic Outcomes. Circulation. 2020; 141: 2113-2116. Go to original source... Go to PubMed...
    4. Hamadeh A, Aldujeli A, Briedis K, et al. Characteristics and Outcomes in Patients Presenting With covid-19 and ST-Segment Elevation Myocardial Infarction. Am J Cardiol. 2020; 131: 1-6. doi: 10.1016/j.amjcard.2020.06.063. Epub 2020 Jul 3. PMID: 32732010; PMCID: PMC7333635. Go to original source... Go to PubMed...
    5. Rodriguez-Leor O, Cid Alvarez AB, Pérez de Prado A, et al. In-hospital outcomes of covid-19 ST-elevation myocardial infarction patients. EuroIntervention. 2021; 16(17): 1426-1433. doi: 10.4244/EIJ-D-20-00935. PMID: 33164893. Go to original source... Go to PubMed...
    6. Garcia S, Albaghdadi MS, Meraj PM, et al. Reduction in ST-segment elevation cardiac catheterization laboratory activations in the United States during covid-19 Pandemic. J Am Coll Cardiol. S0735-1097(20)34913-34915.
    7. De Filippo O, D'Ascenzo F, Angelini F, et al. Reduced rate of hospital admissions for ACS during covid-19 outbreak in northern Italy. N Engl J Med. 2020; 383: 88-89. Go to original source... Go to PubMed...
    8. De Rosa S, Spaccarotella C, Basso C, et al. Reduction of hospitalizations formyocardial infarction in Italy in the covid-19 era. Eur Heart J. 2020; 41: 2083-2088. Go to original source... Go to PubMed...
    9. Giamello JD, Abram S, Bernardi S, et al. The emergency department in the covid-19 era. Who are we missing? Eur J Emerg Med. 2020; 27: 305-306. Go to original source... Go to PubMed...
    10. Metzler B, Siostrzonek P, Binder RK, et al. Decline of acute coronary syndrome admissions in Austria since the outbreak of covid-19: the pandemic response causes cardiac collateral damage. Eur Heart J. 2020; 41: 1852-1853. Go to original source... Go to PubMed...
    11. Tan W, Parikh RV, Chester R, et al. Single center trends in acute coronary syndrome volume and outcomes during the covid-19 pandemic. Cardiol Res. 2020; 11: 256-259. Go to original source... Go to PubMed...
    12. Braiteh N, Rehman WU, Alom M, et al. Decrease in acute coronary syndrome presentations during the COVID-19 pandemic in upstate New York. Am Heart J. 2020; 226: 147-151. doi: 10.1016/j.ahj.2020.05.009. Epub 2020 May 23. PMID: 32569892; PMCID: PMC7244433. Go to original source... Go to PubMed...
    13. Kwok CS, Gale CP, Kinnaird T, et al. Impact of COVID-19 on percutaneous coronary intervention for ST-elevation myocardial infarction. Heart. 2020; 106(23): 1805-1811. doi: 10.1136/heartjnl-2020-317650. Epub 2020 Aug 31. PMID: 32868280. Go to original source... Go to PubMed...
    14. Piccolo R, Esposito G, et al. Population trends in rates of percutaneous coronary revascularization for acute coronary syndromes associated with the covid-19 outbreak. Circulation. 2020; 141: 2035-2037. Go to original source... Go to PubMed...
    15. Lofti A. Assessment of STSegment Elevation Myocardial Infarction Volume Trends During The covid-19 Pandemic, Am J Cardiol 2020; 131: 127-140. Go to original source... Go to PubMed...
    16. Li YH, Huang WC, Hwang JJ; Taiwan Society of Cardiology. No Reduction of ST-segment Elevation Myocardial Infarction Admission in Taiwan During Coronavirus Pandemic. Am J Cardiol. 2020; 131: 133-134. doi: 10.1016/j.amjcard.2020.06.030. Go to original source... Go to PubMed...
    17. Scholz KH, Maier SKG, Maier LS, et al. Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial. Eur Heart J. 2018; 39: 1065-1074. Go to original source... Go to PubMed...
    18. Jing ZC, Zhu HD, Yan XW, Chai WZ, Zhang S. Recommendations from the Pekin Union Medical College Hospital for the management of acute myocardial infarction during the covid-19 outbreak. Eur Heart J. 2020; 14: 1791-1794. Go to original source... Go to PubMed...
    19. Welt FGP, Shah PB, Aronow HD, et al. American College of Cardiology's Interventional Council and the Society for Cardiovascular Angiography and Interventions. Catheterization Laboratory Considerations During the Coronavirus (covid-19) Pandemic: From ACC's Interventional Council and SCAI. J Am Coll Cardiol. 2020; 75: 2372-2375. Go to original source... Go to PubMed...
    20. Romaguera R, Cruz-Gonzalez I, Jurado-Roman A, et al. Considerations on the invasive management of ischemic and structural heart disease during the covid-19 coronavirus outbreak. Consensus statement of the Interventional Cardiology Association and the Ischemic Heart Disease and Acute Cardiac Care Association of the Spanish Society of Cardiology. REC Interv Cardiol. 2020; 2: 112-117. Go to original source...
    21. Tam C-CF, Cheung K-S, Lam S, et al. Impact of coronavirus disease 2019 (covid-19) outbreak on ST-segment-elevation myocardial infarction care in Hong Kong, China. Circ Cardiovasc Qual Outcomes. 2020: 13. Go to original source... Go to PubMed...
    22. Nallamothu BK, Bates ER. Percutaneous coronary intervention versus fibrinolytic therapy in acute myocardial infarction: is timing (almost) everything? Am J Cardiol. 2003; 92: 824-826. doi: 10.1016/s0002-9149(03)00891-9. Go to original source... Go to PubMed...
    23. Bikdeli B, Madhavan MV, Jimenez D, et al. covid-19 and thrombotic or thromboembolicdisease: implications for prevention, antithrombotic therapy, and follow-up. J Am Coll Cardiol 2020; 75: 2950-2973. Go to original source... Go to PubMed...
    24. Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with covid-19. Lancet Haematol 2020; 7: e438-40. Go to original source... Go to PubMed...
    25. Kwong JC, Schwartz KL, Campitelli MA, et al. Acute myocardial infarction after laboratoryconfirmed influenza infection. N Engl J Med 2018; 378: 345-353. Go to original source... Go to PubMed...
    26. Harari R, Bangalore S, Chang E, Shah B. Covid-19 complicated by acute myocardial infarction with extensive thrombus burden and cardiogenic shock.Catheter Cardiovasc Interv. 2020 May 19. Go to original source... Go to PubMed...
    27. Jain N, Berkenbush M, Feldman DC, et all. Effect of covid-19 on prehospital pronouncements and ED visits for stroke and myocardial infarction. Am J Emerg Med. 2021; 43: 46-49. doi: 10.1016/j.ajem.2021.01.024. Epub 2021 Jan 15. PMID: 33503530; PMCID: PMC7836770. Go to original source... Go to PubMed...
    28. Inciardi RM, Lupi L, Zaccone G, Italia L, Raffo M, Tomasoni D, et al. Cardiac involvement in a patient with coronavirus disease 2019 (covid-19). JAMA Cardiol. 2020; 5: 819-824. Go to original source... Go to PubMed...
    29. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with covid-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395: 1054-1062. Go to original source... Go to PubMed...
    30. Ang KP, Quek ZQ, Lee CY, Lu HT. Acute myocarditis mimicking ST-elevation myocardial infarction: a diagnostic challenge for frontline clinicians. Med J Malaysia. 2019; 74: 561-563. Go to PubMed...
    31. Yin S, Huang M, Li D, Tang N. Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARSCoV2 J Thromb Thrombolysis. 2020: 1-4. doi: 10.1007/s11239-020-02105-8. Go to original source... Go to PubMed...

    Return to the content


    Interventional Cardiology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.